Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Improved risk stratification, more effective therapy and better supportive care have resulted in survival rates after childhood cancer of around 80% in developed countries. Treatment however can be harsh, and three in every four childhood cancer survivors (CCS) develop at least one late effect, such as gonadal impairment. | Genetic variation in gonadal impairment in female survivors of childhood cancer A PanCareLIFE study protocol